BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 32785018)

  • 1. PPARs and Angiogenesis-Implications in Pathology.
    Wagner N; Wagner KD
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARs and Myocardial Infarction.
    Wagner KD; Wagner N
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of PPARs in Disease.
    Wagner N; Wagner KD
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors and angiogenesis.
    Biscetti F; Straface G; Pitocco D; Zaccardi F; Ghirlanda G; Flex A
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):751-9. PubMed ID: 19628379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARs and angiogenesis.
    Bishop-Bailey D
    Biochem Soc Trans; 2011 Dec; 39(6):1601-5. PubMed ID: 22103494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PPARs-mediated intracellular signal transduction].
    Fujii H
    Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease.
    Wagner N; Wagner KD
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D; Bystrom J
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARs as targets for metabolic and cardiovascular diseases.
    Cheng PT; Mukherjee R
    Mini Rev Med Chem; 2005 Aug; 5(8):741-53. PubMed ID: 16101410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
    Cheang WS; Tian XY; Wong WT; Huang Y
    Br J Pharmacol; 2015 Dec; 172(23):5512-22. PubMed ID: 25438608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.
    Escandon P; Vasini B; Whelchel AE; Nicholas SE; Matlock HG; Ma JX; Karamichos D
    Exp Eye Res; 2021 Jul; 208():108617. PubMed ID: 34010603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
    Menendez-Gutierrez MP; Roszer T; Ricote M
    Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.
    Youssef J; Badr M
    Br J Pharmacol; 2011 Sep; 164(1):68-82. PubMed ID: 21449912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH; Roufogalis BD
    Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.